Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: The mineralocorticoid pathway is involved in cardiac arrhythmias associated with heart failure through mechanisms that are incompletely understood. Defective regulation of the cardiac ryanodine receptor (RyR) is an important cause of the initiation of arrhythmias. Here, we examined whether the aldosterone pathway might modulate RyR function.

Methods And Results: Using the whole-cell patch clamp method, we observed an increase in the occurrence of delayed afterdepolarizations during action potential recordings in isolated adult rat ventricular myocytes exposed for 48 hours to aldosterone 100 nmol/L, in freshly isolated myocytes from transgenic mice with human mineralocorticoid receptor expression in the heart, and in wild-type littermates treated with aldosterone. Sarcoplasmic reticulum Ca(2+) load and RyR expression were not altered; however, RyR activity, visualized in situ by confocal microscopy, was increased in all cells, as evidenced by an increased occurrence and redistribution to long-lasting and broader populations of spontaneous Ca(2+) sparks. These changes were associated with downregulation of FK506-binding proteins (FKBP12 and 12.6), regulatory proteins of the RyR macromolecular complex.

Conclusions: We suggest that in addition to modulation of Ca(2+) influx, overstimulation of the cardiac mineralocorticoid pathway in the heart might be a major upstream factor for aberrant Ca(2+) release during diastole, which contributes to cardiac arrhythmia in heart failure.

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.108.805804DOI Listing

Publication Analysis

Top Keywords

cardiac ryanodine
8
ryanodine receptor
8
associated downregulation
8
downregulation fk506-binding
8
fk506-binding proteins
8
mineralocorticoid pathway
8
heart failure
8
cardiac
5
ryr
5
mineralocorticoid
4

Similar Publications

Atrial fibrillation (AF), the most common cardiac arrhythmia, is characterized by notable sex differences in clinical presentation, treatment response, and outcomes. Although prevalence is similar between sexes, women often experience more severe symptoms, higher rates of adverse drug effects, and reduced treatment efficacy. To investigate the underlying sex-specific AF mechanisms, we developed and validated male and female human atrial cardiomyocyte models that integrate known sex-based differences in electrophysiology and calcium (Ca) handling under normal sinus rhythm (nSR) and chronic AF (cAF) conditions.

View Article and Find Full Text PDF

Despite clinical need, no new drugs for treating ventricular tachycardia (VT) have emerged for over 20 years. In structural heart disease, posttranslational modifications render intracellular ryanodine receptor-2 (RyR2) calcium release channels leaky, which increases VT risk. Treatment with dantrolene, an RyR2 inhibitor, prevents VT in animal models.

View Article and Find Full Text PDF

Multiple epidemiological studies link cardiac dysfunction with increased levels of air pollution. While cellular mechanisms underlying such dysfunction are yet to be fully elucidated, a proposed mediator of this effect is phenanthrene, a 3-ringed polycyclic aromatic hydrocarbon (PAH). Here, we used ventricular myocytes freshly isolated from healthy female sheep (Ovis aries) to study the impact of acute phenanthrene exposure on cardiac electrophysiology and intracellular Ca cycling in a large mammalian model.

View Article and Find Full Text PDF

Calcium release through the cardiac RyR2 (type-2 ryanodine receptor) is essential for cardiac contraction. RyR2 dysfunction is associated with a spectrum of cardiac pathologies, most notably arrhythmias. While excessive RyR2 activity was historically seen as the driver of arrhythmia, it is now clear that inadequate calcium release is equally detrimental.

View Article and Find Full Text PDF

While calcium (Ca) is a universal cellular messenger, the ionic properties of magnesium (Mg) make it less suited for rapid signaling and more for structural integrity. Still, besides being a passive player, Mg is the only active Ca antagonist, essential for tuning the efficacy of Ca-dependent cardiac excitation-contraction coupling (ECC) and for ensuring cardiac function robustness and stability. This review aims to provide a comprehensive framework to link the structural and molecular mechanisms of Mg/Ca antagonistic binding across key proteins of the cardiac ECC machinery to their physiopathological relevance.

View Article and Find Full Text PDF